PRO-LAD
From Wikipedia, the free encyclopedia
PRO-LAD
|
|
Systematic (IUPAC) name | |
(6aR,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9- hexahydroindolo-[4,3-fg]quinoline-9-carboxamide |
|
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | C22H29N3O |
Mol. mass | 351.50 g/mol |
Synonyms | PRO-LAD, 6-propyl-6-nor-Lysergic acid diethylamide |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | hepatic |
Half life | ? |
Excretion | renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
Controlled in the US via the Federal Analog Act |
Routes | Oral |
PRO-LAD, also known as 6-propyl-6-nor-lysergic acid diethylamide, is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PRO-LAD is a hallucinogenic drug similar to LSD, and is around as potent as LSD itself with an active dose reported at between 100 and 200 micrograms.
PRO-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
[edit] External links
|
|